Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$941M |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$933M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$657M |
| 4 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$511M |
| 5 |
Microsoft
MSFT
|
+$459M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Apple
AAPL
|
+$770M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$642M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$337M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.44% |
| 2 | Consumer Discretionary | 1.85% |
| 3 | Financials | 1.42% |
| 4 | Communication Services | 1.33% |
| 5 | Healthcare | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8351
CALL
Lexicon Pharmaceuticals
LXRX
$1.07B
| $41.3K | ﹤0.01% |
21,600
-5,900
| -21% | -$12.6K |
|
8352
Dominari Holdings
DOMH
$63.8M
| $41.3K | ﹤0.01% |
12,577
+1,375
| +12% | +$6.62K |
|
|
TCRR
8353
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $41.2K | ﹤0.01% |
41,295
+25,553
| +162% | +$34.4K |
|
8354
VEON
VEON
$3.87B
| $40.9K | ﹤0.01% |
3,340
+2,506
| +300% | +$26.9K |
|
|
ACHL
8355
DELISTED
Achilles Therapeutics
ACHL
| $40.8K | ﹤0.01% |
+45,332
| New | +$76.3K |
|
8356
SmartRent
SMRT
$261M
| $40.7K | ﹤0.01% |
16,741
-5,146
| -24% | -$12.7K |
|
8357
Daktronics
DAKT
$1.03B
| $40.5K | ﹤0.01% |
+14,362
| New | +$44.2K |
|
8358
American Well
AMWL
$231M
| $40.3K | ﹤0.01% |
713
-5,242
| -88% | -$378K |
|
|
SHCR
8359
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $40.3K | ﹤0.01% |
25,198
-9,063
| -26% | -$16.8K |
|
|
ADVM
8360
DELISTED
Adverum Biotechnologies
ADVM
| $40.1K | ﹤0.01% |
6,916
+5,534
| +400% | +$42K |
|
8361
PUT
IonQ
IONQ
$17.2B
| $40K | ﹤0.01% |
11,600
-79,000
| -87% | -$381K |
|
8362
Galectin Therapeutics
GALT
$315M
| $40K | ﹤0.01% |
+35,398
| New | +$47.2K |
|
|
MTCR
8363
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $39.6K | ﹤0.01% |
88,364
-84,964
| -49% | -$35.1K |
|
8364
PUT
Gossamer Bio
GOSS
$86.1M
| $39.3K | ﹤0.01% |
+18,100
| New | +$149K |
|
8365
PUT
Bakkt Inc
BKKT
$342M
| $39.3K | ﹤0.01% |
1,320
-1,976
| -60% | -$92.2K |
|
|
SLGC
8366
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $39.1K | ﹤0.01% |
15,575
-21,258
| -58% | -$59.3K |
|
8367
Aethlon Medical
AEMD
$1.62M
| $38.6K | ﹤0.01% |
35
+31
| +775% | +$56.5K |
|
8368
Korro Bio
KRRO
$199M
| $38.6K | ﹤0.01% |
201
-291
| -59% | -$29.9K |
|
8369
Cipher Digital
CIFR
$6.78B
| $38.4K | ﹤0.01% |
68,531
+54,059
| +374% | +$47K |
|
|
KRON
8370
DELISTED
Kronos Bio
KRON
| $38.2K | ﹤0.01% |
+23,561
| New | +$54.2K |
|
|
DFTX
8371
PUT
Definium Therapeutics
DFTX
$5.99B
| $38.2K | ﹤0.01% |
17,347
-59,527
| -77% | -$165K |
|
|
IMMP
8372
Immutep
IMMP
$56.6M
| $38.1K | ﹤0.01% |
+21,785
| New | +$43.2K |
|
|
BWAY
8373
Brainsway
BWAY
$615M
| $38K | ﹤0.01% |
+37,482
| New | +$51.6K |
|
8374
CALL
Brookdale Senior Living
BKD
$3.27B
| $37.9K | ﹤0.01% |
+13,900
| New | +$52K |
|
|
SUNW
8375
CALL
DELISTED
Sunworks, Inc.
SUNW
| $37.9K | ﹤0.01% |
24,000
-7,400
| -24% | -$16.6K |
|
Similar funds
Jane Street's Q4 2022 Portfolio in Review
As of Q4 2022, Jane Street held 11,014 positions worth $216B, down 5.4% from $229B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jane Street withdrew a net $7.38B in Q4 2022, closing 1,990 positions and reducing 4,301 holdings. Its most notable exit was Twitter, Inc., an estimated $299M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jane Street opened a new position in Vanguard Total International Stock ETF worth $965M.
- Jane Street's largest Q4 2022 buy was Vanguard Total International Stock ETF: 18,650,377 shares worth $965M.
- Jane Street added most to SPDR Gold Trust in Q4 2022, an estimated $941M increase.
- Jane Street's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
- Jane Street fully exited Twitter, Inc. in Q4 2022, selling an estimated $299M.
- Jane Street's ten largest holdings make up 32% of its $216B portfolio in Q4 2022.
- Jane Street opened 1,402 new positions and closed 1,990 in Q4 2022.
- Jane Street's portfolio value fell 5.4% quarter-over-quarter to $216B.
Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.